Géraud, A <br/><br/>
Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer.  [electronic resource] 

 -  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique  Jun 2016 
 - 312-3 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1769-6658 
<br/><br/><label>Standard No.: </label>10.1016/j.canrad.2016.03.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ado-Trastuzumab Emtansine<br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Bone Neoplasms--secondary<br/>Breast Neoplasms--metabolism<br/>Chemoradiotherapy<br/>Female<br/>Humans<br/>Maytansine--analogs & derivatives<br/>Middle Aged<br/>Radiation Dose Hypofractionation<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab